Monoclonal Antibodies for Chronic Pain Treatment: Present and Future

Chronic pain remains a major problem worldwide, despite the availability of various non-pharmacological and pharmacological treatment options. Therefore, new analgesics with novel mechanisms of action are needed. Monoclonal antibodies (mAbs) are directed against specific, targeted molecules involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Robles, Eva M., Girón, Rocío, Paniagua, Nancy, Rodríguez-Rivera, Carmen, Pascual, David, Goicoechea, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508878/
https://www.ncbi.nlm.nih.gov/pubmed/34638667
http://dx.doi.org/10.3390/ijms221910325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508878/
https://www.ncbi.nlm.nih.gov/pubmed/34638667
http://dx.doi.org/10.3390/ijms221910325

Ejemplares similares